Bristol-Myers Squibb Company - Related News

OtherSeeking Alpha

Bristol Myers Squibb's Breakout Is Here: Portfolio Renewal Gaining Momentum

Growth assets now comprise 58.2% of Bristol Myers Squibb Company's revenues, with the legacy portfolio also reporting a promising deceleration in top-line erosion cadence. The successful Opdivo/Qvanti

6 days ago

M&ACNBC

AstraZeneca may buck a decade of pharma strategy to buy U.S. scale

Reported talks of a tie-up between two industry giants could deliver instant U.S. scale for AstraZeneca through Bristol Myers Squibb's U.S.-centric business, but at the cost of slower growth and integ

last month

NewsProactive Investors

Dow futures jump but Nasdaq flat ahead of busy week for Wall Street

Wall Street is set for a mostly higher start to August, although Nasdaq futures are flat as investors continue to assess whether Friday's technology rebound has further to run. Dow Jones futures were

last month

M&AProactive Investors

Analysts baffled by AstraZeneca's interest in Bristol Myers Squibb

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) shares fell 6% to 11,872p on Monday, the steepest decline in the FTSE 100, as analysts struggled to explain why Britain's largest drugmaker would want to buy Bris

last month

ProductSeeking Alpha

Wall Street Breakfast Podcast: Say Hello To Qwen3.8-Max

Alibaba Group (BABA) surges after unveiling Qwen3.8-Max, its flagship AI model, claiming performance on par with global leaders. BABA's Qwen3.8-Max, built on 2.4T parameters, outperformed Moonshot's K

last month

M&ANew York Post

AstraZeneca holds talks with Bristol Myers Squibb on $400B megadeal: report

The deal could create one of the world's biggest pharmaceutical groups with a combined value of nearly $400 billion.

last month

M&ACNBC

AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

UK pharmaceutical company AstraZeneca is considering a deal to merge with its U.S. competitor Bristol Myers Squibb, according to a report by the Financial Times. The megadeal would be one of the large

last month

EarningsFXEmpire

The Week Ahead: Fed, GDP and Big Tech Earnings Set the Tone for U.S. Stocks

Markets face a pivotal week with the Fed, Core PCE, GDP and earnings from Microsoft, Meta, Apple and Amazon all set to drive trading sentiment.

2 months ago

DividendSeeking Alpha

Bristol Myers Squibb: Pain First, Payoff Later?

Bristol Myers Squibb remains a Strong Buy, supported by steady performance and undervaluation despite recent underperformance versus the benchmark. BMY boasts a 4.43% forward dividend yield, over 2.7x

2 months ago